Patent ID: 11866706
Assignee: MEHARRY MEDICAL COLLEGE
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 0:
1. A method of reducing the replication of Zika virus (ZIKV) in an isolated host cell, the method comprising contacting the host cell with an effective amount of an antiviral agent that restricts the replication of ZIKV in a cell, the antiviral agent comprising a phosphorodiamidate morpholino oligomer (PMO) comprising an antisense sequence of:, (SEQ ID NO: 3)

5′-CAT GAC CAG AAA CTC TCG TTT CCA A-3′  

or

 

(SEQ ID NO: 5)

5′-CAT GGA GTC TCT GGT CTT TCC CAG C-3′.